Changes in Beneficial Ownership · 4
STERIS plc
STENYSEEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1794519135.xml
Filing details
- Report period
- 2026-11-11
- Issuer
- STERIS plc
- Issuer CIK
- 0001757898
- Trading symbol
- STE
Reporting owner 1
- Name
- Burton Karen L
- Reporting owner CIK
- 0001697095
- Relationship
- Officer
- Officer title
- Sr. Vice Pres., CFO
- Address
- 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND, L2, D02 R296
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | 2026-11-11 | M · Form 4 | 5,880 | A | 147.05 | 18,836 | D |
| Ordinary Shares | 2026-11-11 | S · Form 4 | 5,880 | D | 255.62[F1] | 12,956[F2] | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | 147.05 | 2026-11-11 | M · Form 4 | 5,880 | D | 0 | [F3] | 2029-05-31 | Ordinary Shares | 5,880 | 0 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F1
- Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.↩ 1
- F2
- As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029.↩ 1
- F3
- This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.↩ 1
Signature 1
- Signed
- /s/ John P. Ubbing, Authorized Representative under Power of Attorney
- Date
- 2026-11-12
Company context
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit www.steris.com.